USD 4.92
(-2.19%)
Year | Total Debt | Total Debt Growth |
---|---|---|
2023 | 44.78 Billion EUR | 8.4% |
2022 | 41.32 Billion EUR | 4.53% |
2021 | 39.53 Billion EUR | -4.87% |
2020 | 41.55 Billion EUR | 6.87% |
2019 | 38.88 Billion EUR | -4.39% |
2018 | 40.66 Billion EUR | 207.89% |
2017 | 13.2 Billion EUR | -27.68% |
2016 | 18.26 Billion EUR | -2.85% |
2015 | 18.8 Billion EUR | -2.29% |
2014 | 19.24 Billion EUR | 167.07% |
2013 | 7.2 Billion EUR | -19.16% |
2012 | 8.91 Billion EUR | -18.4% |
2011 | 10.92 Billion EUR | -1.1% |
2010 | 11.04 Billion EUR | -8.76% |
2009 | 12.1 Billion EUR | -22.93% |
2008 | 15.7 Billion EUR | 13.77% |
2007 | 13.8 Billion EUR | -4.34% |
2006 | 14.42 Billion EUR | 105.9% |
2005 | 7 Billion EUR | -27.88% |
2004 | 9.71 Billion EUR | 3.25% |
2003 | 9.4 Billion EUR | -7.46% |
2002 | 10.16 Billion EUR | 37.54% |
2001 | 7.39 Billion EUR | 10.64% |
2000 | 6.68 Billion EUR | 49.63% |
1999 | 4.46 Billion EUR | -5.58% |
1998 | 4.73 Billion EUR | 0.0% |
Year | Total Debt | Total Debt Growth |
---|---|---|
2024 Q1 | 46.26 Billion EUR | 3.3% |
2024 Q2 | 46.57 Billion EUR | 0.67% |
2023 Q4 | 44.78 Billion EUR | -5.56% |
2023 Q1 | 43.29 Billion EUR | 4.79% |
2023 Q3 | 47.42 Billion EUR | 1.95% |
2023 Q2 | 46.51 Billion EUR | 7.43% |
2023 FY | 44.78 Billion EUR | 8.4% |
2022 Q3 | 44.79 Billion EUR | 0.35% |
2022 Q2 | 44.63 Billion EUR | 4.91% |
2022 FY | 41.32 Billion EUR | 4.53% |
2022 Q1 | 42.54 Billion EUR | 7.63% |
2022 Q4 | 41.32 Billion EUR | -7.75% |
2021 Q2 | 40.37 Billion EUR | -5.82% |
2021 FY | 39.53 Billion EUR | -4.87% |
2021 Q3 | 41.76 Billion EUR | 3.45% |
2021 Q1 | 42.86 Billion EUR | 3.16% |
2021 Q4 | 39.53 Billion EUR | -5.35% |
2020 Q2 | 41.31 Billion EUR | 3.27% |
2020 Q3 | 43.45 Billion EUR | 5.16% |
2020 Q4 | 41.55 Billion EUR | -4.37% |
2020 FY | 41.55 Billion EUR | 6.87% |
2020 Q1 | 40.01 Billion EUR | 2.91% |
2019 Q2 | 43.32 Billion EUR | 2.83% |
2019 Q4 | 38.88 Billion EUR | -11.2% |
2019 FY | 38.88 Billion EUR | -4.39% |
2019 Q3 | 43.78 Billion EUR | 1.05% |
2019 Q1 | 42.13 Billion EUR | 3.62% |
2018 FY | 40.66 Billion EUR | 207.89% |
2018 Q4 | 40.66 Billion EUR | -7.26% |
2018 Q3 | 43.85 Billion EUR | -15.88% |
2018 Q2 | 52.12 Billion EUR | 271.45% |
2018 Q1 | 14.03 Billion EUR | 6.25% |
2017 Q2 | 19.2 Billion EUR | 1.15% |
2017 Q3 | 16.11 Billion EUR | -16.08% |
2017 Q4 | 13.2 Billion EUR | -18.05% |
2017 FY | 13.2 Billion EUR | -27.68% |
2017 Q1 | 18.98 Billion EUR | 3.96% |
2016 FY | 18.26 Billion EUR | -2.85% |
2016 Q4 | 18.26 Billion EUR | -5.02% |
2016 Q1 | 20.31 Billion EUR | 8.03% |
2016 Q3 | 19.22 Billion EUR | -2.43% |
2016 Q2 | 19.7 Billion EUR | -2.96% |
2015 Q3 | 22.77 Billion EUR | -8.36% |
2015 FY | 18.8 Billion EUR | -2.29% |
2015 Q4 | 18.8 Billion EUR | -17.46% |
2015 Q1 | 23.43 Billion EUR | 21.79% |
2015 Q2 | 24.85 Billion EUR | 6.06% |
2014 Q4 | 19.24 Billion EUR | 32.61% |
2014 Q1 | 12.24 Billion EUR | 69.92% |
2014 Q2 | 11.59 Billion EUR | -5.26% |
2014 Q3 | 14.5 Billion EUR | 25.11% |
2014 FY | 19.24 Billion EUR | 167.07% |
2013 Q3 | 9.92 Billion EUR | -12.19% |
2013 Q4 | 7.2 Billion EUR | -27.4% |
2013 FY | 7.2 Billion EUR | -19.16% |
2013 Q1 | 9.55 Billion EUR | 7.19% |
2013 Q2 | 11.3 Billion EUR | 18.3% |
2012 Q4 | 8.91 Billion EUR | -8.58% |
2012 Q2 | 9.9 Billion EUR | -14.89% |
2012 Q3 | 9.74 Billion EUR | -1.6% |
2012 Q1 | 11.63 Billion EUR | 6.57% |
2012 FY | 8.91 Billion EUR | -18.4% |
2011 FY | 10.92 Billion EUR | -1.1% |
2011 Q4 | 10.92 Billion EUR | -2.86% |
2011 Q3 | 11.24 Billion EUR | 0.92% |
2011 Q2 | 11.13 Billion EUR | -0.58% |
2011 Q1 | 11.2 Billion EUR | 1.47% |
2010 Q3 | 11.98 Billion EUR | -13.33% |
2010 FY | 11.04 Billion EUR | -8.76% |
2010 Q2 | 13.82 Billion EUR | 3.55% |
2010 Q4 | 11.04 Billion EUR | -7.87% |
2010 Q1 | 13.35 Billion EUR | 10.35% |
2009 Q4 | 12.1 Billion EUR | 0.0% |
2009 FY | 12.1 Billion EUR | -22.93% |
2008 Q1 | 14.4 Billion EUR | 4.38% |
2008 Q2 | 14.93 Billion EUR | 3.68% |
2008 FY | 15.7 Billion EUR | 13.77% |
2008 Q4 | 15.7 Billion EUR | 1.8% |
2008 Q3 | 15.42 Billion EUR | 3.27% |
2007 Q2 | 15.95 Billion EUR | -12.8% |
2007 FY | 13.8 Billion EUR | -4.34% |
2007 Q4 | 13.8 Billion EUR | -22.41% |
2007 Q1 | 18.29 Billion EUR | 26.8% |
2007 Q3 | 17.78 Billion EUR | 11.51% |
2006 Q1 | - EUR | -100.0% |
2006 Q4 | 14.42 Billion EUR | -33.78% |
2006 Q3 | 21.78 Billion EUR | 80.62% |
2006 FY | 14.42 Billion EUR | 105.9% |
2006 Q2 | 12.06 Billion EUR | 0.0% |
2005 Q3 | - EUR | -100.0% |
2005 Q4 | 7 Billion EUR | 0.0% |
2005 FY | 7 Billion EUR | -27.88% |
2005 Q1 | 9.37 Billion EUR | -3.53% |
2005 Q2 | 9.97 Billion EUR | 6.47% |
2004 Q3 | 8.99 Billion EUR | -3.95% |
2004 Q1 | 9.68 Billion EUR | 2.94% |
2004 FY | 9.71 Billion EUR | 3.25% |
2004 Q4 | 9.71 Billion EUR | 8.05% |
2004 Q2 | 9.36 Billion EUR | -3.36% |
2003 FY | 9.4 Billion EUR | -7.46% |
2003 Q4 | 9.4 Billion EUR | 272.7% |
2003 Q3 | 2.52 Billion EUR | 4.34% |
2003 Q2 | 2.41 Billion EUR | 0.0% |
2003 Q1 | - EUR | -100.0% |
2002 Q3 | - EUR | 0.0% |
2002 Q4 | 10.16 Billion EUR | 0.0% |
2002 Q1 | - EUR | -100.0% |
2002 FY | 10.16 Billion EUR | 37.54% |
2002 Q2 | - EUR | 0.0% |
2001 Q2 | - EUR | 0.0% |
2001 Q1 | - EUR | 0.0% |
2001 Q4 | 7.39 Billion EUR | 0.0% |
2001 Q3 | - EUR | 0.0% |
2001 FY | 7.39 Billion EUR | 10.64% |
2000 FY | 6.68 Billion EUR | 49.63% |
1999 FY | 4.46 Billion EUR | -5.58% |
1998 FY | 4.73 Billion EUR | 0.0% |
Name | Total Debt | Total Debt Difference |
---|---|---|
AstraZeneca PLC | 28.58 Billion USD | -56.706% |
Bristol-Myers Squibb Company PFD CONV 2 | 41.46 Billion USD | -8.019% |
CSPC Pharmaceutical Group Limited | 99.64 Million USD | -44848.128% |
Clarus Therapeutics Holdings, Inc. | 42.26 Million USD | -105861.816% |
Novartis AG | 26.34 Billion USD | -69.99% |
PT Kalbe Farma Tbk. | 40.4 Million USD | -110748.046% |